Literature DB >> 27888000

Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings.

Abraham Sunday Alabi1, Afsatou Ndama Traoré2, Marguerite Massinga Loembe3, Ulysse Ateba-Ngoa4, Matthias Frank5, Ayola Akim Adegnika4, Bertrand Lell4, Jocelyn Mahoumbou6, Carsten Köhler7, Peter Gottfried Kremsner8, Martin Peter Grobusch9.   

Abstract

Both routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Médicales de Lambaréné (CERMEL) took a strategic decision to expand its activities by building TB laboratory capacity to address research questions and to improve routine diagnostic and treatment capacity. Over the past 7 years, a standard laboratory has been developed that is contributing significantly to TB diagnosis, treatment, and control in Gabon; training has also been provided for TB research staff in Central Africa. CERMEL has a cordial relationship with the Gabon National TB Control Programme (PNLT), which has culminated in a successful Global Fund joint application. This endeavour is considered a model for similar developments needed in areas of high TB prevalence and where TB control remains poor to date.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CERMEL; Gabon; Laboratory capacity building; Research; South–North collaboration; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27888000     DOI: 10.1016/j.ijid.2016.11.404

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field.

Authors:  U Ateba-Ngoa; J R Edoa; B R Adegbite; E G Rossatanga; D Madiou; A Mfoumbi; C Mevyann; P Achimi Agbo; J Mahoumbou; S Gould; B Lell; A A Adegnika; C Köhler; P G Kremsner; M Massinga-Loembe; A Alabi; M P Grobusch
Journal:  Infection       Date:  2019-05-09       Impact factor: 3.553

Review 2.  Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon.

Authors:  Michael Ramharter; Selidji T Agnandji; Ayôla A Adegnika; Bertrand Lell; Ghyslain Mombo-Ngoma; Martin P Grobusch; Matthew McCall; Riko Muranaka; Andrea Kreidenweiss; Thirumalaisamy P Velavan; Meral Esen; Frieder Schaumburg; Abraham Alabi; Christiane Druml; Benjamin Mordmüller; Carsten Köhler; Peter G Kremsner
Journal:  Wien Klin Wochenschr       Date:  2021-01-04       Impact factor: 1.704

3.  Tuberculosis infection control measures in healthcare facilities in Moyen-Ogooué Province, Gabon.

Authors:  Anja Vigenschow; Bayodé Romeo Adegbite; Jean-Ronald Edoa; Abraham Alabi; Akim A Adegnika; Martin P Grobusch; Marguerite Massinga-Loembe
Journal:  BMC Health Serv Res       Date:  2021-11-05       Impact factor: 2.655

4.  Non-communicable disease co-morbidity and associated factors in tuberculosis patients: A cross-sectional study in Gabon.

Authors:  B R Adegbite; J R Edoa; Jbp Agbo Achimi Abdul; M Epola; C Mevyann; J C Dejon-Agobé; J F Zinsou; Y J Honkpehedji; S G Mpagama; A S Alabi; P G Kremsner; K Klipstein-Grobusch; A A Adegnika; M P Grobusch
Journal:  EClinicalMedicine       Date:  2022-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.